Revvityブログ
発見から治療までのイノベーションを促進
Latest
From policy to practice: what FDA's 2025 direction means for your precision medicine pipeline.
Cell and Gene Therapy
December 8, 2025 - 5 min read
Cancer
Tips on establishing a reliable cell free DNA (cfDNA) workflow from plasma samples.
November 26, 2024 -
6 min read
Physiological Model Solutions, Cancer
Why you should use 3D cell models for high throughput screening.
October 24, 2024 -
4 min read
NGS, Cancer, Biomarker Detection
Why are miRNAs promising non-invasive Biomarkers?
October 23, 2024 -
5 min read
Cell and Gene Therapy, Biologics, Cancer
What is Image Cytometry?
September 27, 2024 -
4 min read
Cell and Gene Therapy, Biologics, Cancer
Your cell counts will never be perfect – here’s why.
September 26, 2024 -
6 min read
Cell and Gene Therapy, Biologics, Cancer
Understanding autophagy.
September 25, 2024 -
2 min read
Cell and Gene Therapy, Biologics, Cancer
Is your Trypan blue rupturing dead or dying immune cells leading to an overestimation of cell viability?
September 25, 2024 -
10 min read
Cancer
Recommendations from the AML MRD advisory board and the utility of Mimix Reference Standards in AML research.
September 17, 2024 -
4 min read
Cell and Gene Therapy, Biologics, Cancer
How to count cells using a hemocytometer.
September 13, 2024 -
1 min read
Physiological Model Solutions, Cancer
Integrating live-cell imaging with optimized organoid pipelines for prostate cancer drug testing.
July 24, 2024 -
3 min read
